This is still a ~1.5m valued Biotech company with is an outlier based on ASX history. Excluding the biotech boom we had couple of years or so ago where companies like IMU were valued at ~2b or so, CU6 is an exception and to a certain extent for good reasons but still expensive based on ASX casino.
For long term holders, it's still an amazing outcome and perhaps an opportunity for investors on the fence to get it. Will be interesting to see where the down trend stabilizes.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.11 |
Change
-0.200(4.64%) |
Mkt cap ! $1.329B | |||
| Open | High | Low | Value | Volume |
| $4.20 | $4.27 | $4.09 | $7.447M | 1.792M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $4.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.12 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |